The public knew that CD12 trial failed. Soooooooo LL was not a threat to the public. A CEO points out good data within the trial!! Is a CEO not allowed to point out good data within a trial????? The FDA said THEY would help with setting up a new trial!! Ask yourself, who was the FDA protecting with the hit piece letter? The public was safe from LL, it failed the trial, correct?? Was the public with SIGNIFICANT INTEREST (bullsh#t) in any danger?? Explain to me how that letter protected the public? The public was completely SAFE!! How can the drug hurt anyone when it failed trial and is not approved. Ask yourself again, how many people knew about LL and would read a PR on an OTC company on a failed trial. ITS BS... FDA sabotaged trial with allowing only two doses when the company requested 4 doses. Even with the purposeful sabotage (IMO) of the trial there was very interesting data (a sub group) that did very well. What was the sub group you ask? The sub group that got shots the first two weeks. FDA reaction?? NOT INTERESTED!!! But we will help in future trials!! LMAO... can’t prove it but FDA didn’t want LL to be approved or get an EUA. LL was not the only therapeutic that was poo poooed!! Conclusion, FDA wanted to fight pandemic with vaccines and a viable therapeutic was a hindrance.
News 
Market Data 
Discover 
